Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness
Authors
Keywords
Type 2 diabetes mellitus, Novel antidiabetic agents, Usage trends, Comparative effectiveness, Safety
Journal
Current Diabetes Reports
Volume 16, Issue 6, Pages -
Publisher
Springer Nature
Online
2016-04-14
DOI
10.1007/s11892-016-0744-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study
- (2015) Concetta Rafaniello et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes
- (2015) David M. Nathan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
- (2015) Jinsong Geng et al. PHARMACOECONOMICS
- Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013
- (2015) Kristin K. Clemens et al. PLoS One
- Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time
- (2015) Carla Torre et al. Primary Care Diabetes
- Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs
- (2015) Vishal Ahuja et al. Journal of Managed Care & Specialty Pharmacy
- Use of Antidiabetic Drugs in the U.S., 2003–2012
- (2014) Christian Hampp et al. DIABETES CARE
- The long-term efficacy and safety of DPP-IV inhibitors monotherapy and in combination with metformin in 18 980 patients with type-2 diabetes mellitus-a meta-analysis
- (2014) Xia Liu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis
- (2014) Dongsheng Cheng et al. PLoS One
- Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis
- (2014) Andrea C Tricco et al. BMJ Open
- Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden
- (2014) Aliasghar A. Kiadaliri et al. Diabetes Therapy
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
- (2013) Wendy L. Bennett et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis
- (2013) D. Wu et al. DIABETES OBESITY & METABOLISM
- Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials
- (2013) Yifei Zhang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Use of exenatide and liraglutide in Denmark: a drug utilization study
- (2013) Anton Pottegård et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Trends in Antidiabetic Prescription Patterns in Japan From 2005 to 2011
- (2013) Takahide Kohro et al. International Heart Journal
- Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32)
- (2013) Mariko Oishi et al. Journal of Diabetes Investigation
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- State Medicaid Programs Did Not Make Use Of Prior Authorization To Promote Safer Prescribing After Rosiglitazone Warning
- (2012) Joseph S. Ross et al. HEALTH AFFAIRS
- Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert
- (2011) Kathryn M. Hurren et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003-2009
- (2010) A. Cohen et al. DIABETES CARE
- Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus
- (2010) Lizheng Shi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone
- (2010) Nilay D. Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projecting the Future Diabetes Population Size and Related Costs for the U.S.
- (2009) E. S. Huang et al. DIABETES CARE
- Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis
- (2009) Kristian B. Filion et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Temporal trends in anti-diabetes drug use in tricare following safety warnings in 2007 about rosiglitazone
- (2009) Kate A. Stewart et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
- (2008) G. Caleb Alexander et al. ARCHIVES OF INTERNAL MEDICINE
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now